- Karmastock
- uploaded: Nov 8, 2011
- Hits: 488
Description:
Opexa Therapeutics Incorporated - symbol OPXA - reported that its lead drug candidate Tovaxin has been granted Fast Track designation by the FDA for the treatment of patients with Secondary Progressive Multiple Sclerosis
Tags:
Categories:
0 comments
No comments yet.











